MR-visible lipids and the tumor microenvironment

NMR in Biomedicine

Volumn 24, Issue 6, 2011, Pages 592-611

  Delikatny, E James ^a   Chawla, Sanjeev ^a   Leung, Daniel Joseph ^a   Poptani, Harish ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

(N)MR visible lipids; Apoptosis; Cholesterol esters; Lipid droplets; Mobile lipids; MRI; MRS; Neutral lipids; Triglycerides; Tumor microenvironment

Indexed keywords

(N)MR-VISIBLE LIPIDS; CHOLESTEROL ESTERS; LIPID DROPLETS; MOBILE LIPIDS; MRS; NEUTRAL LIPID; TRIGLYCERIDES; TUMOR MICROENVIRONMENT;

ANIMALS; BRAIN MODELS; CELL CULTURE; CELL DEATH; CHOLESTEROL; DETOXIFICATION; DISEASES; DROPS; ESTERIFICATION; ESTERS; TUMORS;

LIPIDS;

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CREATINE; CREATINE PHOSPHATE; CYCLOSPORIN A; DAUNORUBICIN; DEFEROXAMINE; DEMECOLCINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FAS ANTIBODY; FAT DROPLET; FATTY ACID; FLUOROURACIL; GAMMA INTERFERON; GLYCEROPHOSPHORYLCHOLINE; LACTIC ACID; LONIDAMINE; MEMBRANE PHOSPHOLIPID; PACLITAXEL; PHOSPHORYLCHOLINE; POLYUNSATURATED FATTY ACID; RAZOXANE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TAURINE; TETRAPHENYLPHOSPHONIUM CHLORIDE; TRIACYLGLYCEROL; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOSE TISSUE; APOPTOSIS; BIOACCUMULATION; BIOGENESIS; BRAIN CANCER; BRAIN LYMPHOMA; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; COMPETITIVE INHIBITION; DECARBOXYLATION; DETOXIFICATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ENDOPLASMIC RETICULUM; EX VIVO STUDY; FATTY ACID OXIDATION; FIBROBLAST; HELA CELL; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HODGKIN DISEASE; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATORY CELL; IONIZING RADIATION; LIPID ANALYSIS; LIPID METABOLISM; LIPOGENESIS; LIPOSOMAL DELIVERY; LYMPHOMA; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POINT RESOLVED SPECTROSCOPY; PRIMARY CEREBRAL LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIGNAL TRANSDUCTION; SPECTROSCOPY; SUBCUTANEOUS FAT; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT;

ANIMALS; CELLS; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; NEOPLASMS; TUMOR MICROENVIRONMENT;

ANIMALIA;

EID: 79960845686     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1661     Document Type: Review

References (165)

1. 1H MR-visible lipid in human glioma cells is independent of the cell cycle.Int. J. Oncol. 1997;11:543-550.
2. Hansen SH, Andersen ML, Cornett C, Gradinaru R, Grunnet N.A role for taurine in mitochondrial function.J. Biomed. Sci. 2010;17 (Suppl 1):S23.
3. Sathasivam N, Brammah S, Wright LC, Delikatny EJ.Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine.Biochim. Biophys. Acta, 2003;1633:149-160.
4. 1H MRS at 14.1 T.NMR Biomed. 2010;23:578-583.
5. 1H NMR spectroscopy of the mouse brain at 9.4 T.Magn. Reson. Med. 2004;52:478-484.
6. 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs.7T.Magn. Reson. Med. 2009;62:868-879.
7. Glunde K, Jie C, Bhujwalla ZM.Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.Cancer Res. 2004;64:4270-4276.
8. Podo F.Tumour phospholipid metabolism.NMR Biomed. 1999;12:413-439.
9. Williams E, Hamilton JA, Jain MK, Allerhand A, Cordes EH, Ochs S.Natural abundance carbon-13 nuclear magnetic resonance spectra of the canine sciatic nerve.Science, 1973;181:869-871.
10. Mountford CE, Mackinnon WB, Russell P, Rutter A, Delikatny EJ.Human cancers detected by proton MRS and chemical shift imaging ex vivo.Anticancer Res. 1996;16:1521-1531.
11. de Certaines JD, Le Moyec L, Sequin F, Eliat PA, Constans JM.Nuclear magnetic resonance spectroscopy of lipids in cancer.Curr. Org. Chem. 2007;11:529-546.
12. 1H NMR visible lipids in the life and death of cells.Trends Biochem. Sci. 2000;25:357-362.
13. Mountford CE, Doran S, Lean CL, Russell P.Proton MRS can determine the pathology of human cancers with a high level of accuracy.Chem. Rev. 2004;104:3677-3704.
14. Corbin IR, Furth EE, Pickup S, Siegelman ES, Delikatny EJ.In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy.Biochim. Biophys. Acta, 2009;1791:757-763.
15. Holmes KT, Mountford CE.Identification of triglyceride in malignant cell membranes.J. Magn. Reson. 1991;93:407-409.
16. Cross KJ, Holmes KT, Mountford CE, Wright PE.Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods.Biochemistry, 1984;23:5895-5897.
17. Delikatny EJ, Lander CM, Jeitner TM, Hancock R, Mountford CE.Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response.Int. J. Cancer, 1996;65:238-245.
18. Mountford CE, Grossman G, Reid G, Fox RM.Characterization of transformed cells and tumours by proton nuclear magnetic resonance spectroscopy.Cancer Res. 1982;42:2270-2276.
19. Delikatny EJ, Russell P, Hunter JC, Hancock R, Atkinson K, van Haaften-Day C, Mountford CE.Proton MR and cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions.Radiology, 1993;188:791-796.
20. 13C nuclear magnetic resonance spectra of the lipids in normal and SV 40 virus-transformed hamster embryo fibroblast membranes.Biochim. Biophys. Acta, 1975;382:311-321.
21. Delikatny EJ, Roman SK, Hancock R, Jeitner TM, Lander CM, Rideout DC, Mountford CE.Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line.Int. J. Cancer, 1996;67:72-79.
22. 1H NMR-visible triacylglycerol in human neutrophils: high fatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol.Eur. J. Biochem. 2000;267:68-78.
23. Dingley AJ, King NJC, King GF.An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes.Biochemistry, 1992;31:9098-9106.
24. 1H NMR studies of membrane changes during the activation of primary T-lymphocytes.Immunomethods, 1994;4:127-138.
25. 1H Magnetic resonance spectroscopy of primary human and murine cells of the myeloid lineage.Immunomethods, 1994;4:188-198.
26. King NJC, Ward MH, Holmes KT.Magnetic resonance studies of murine macrophages: proliferation is not a prerequisite for acquisition of an 'activated' high resolution spectrum.FEBS Lett. 1991;287:97-101.
27. 1 phase of cell cycle.Magn. Reson. Med. 1990;16:1-8.
28. Lindskog M, Spenger C, Klason T, Jarvet J, Graslund A, Johnsen JI, Ponthan F, Douglas L, Nordell B, Kogner P.Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.Cancer Lett. 2005;228:247-255.
29. Sibtain NA, Howe FA, Saunders DE.The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.Clin. Radiol. 2007;62:109-119.
30. Mountford CE, Mackinnon WB, Bloom M, Burnell EE, Smith ICP.NMR methods for characterising the state of the surfaces of complex mammalian cells.J. Biochem. Biophys. Methods, 1984;9:323-330.
31. Mackinnon WB, May GL, Mountford CE.Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells.Eur. J. Biochem. 1992;205:827-839.
32. Le Moyec L, Millot G, Tatoud R, Calvo G, Eugène M.Lipid signals detected by NMR proton spectroscopy of whole cells are not correlated to lipid droplets evidenced by the Nile red staining.Cell. Mol. Biol. 1997;43:703-709.
33. 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets.NMR Biomed. 1989;2:161-164.
34. 1H MR spectra of neutrophils.Magn. Reson. Med. 1994;31:212-217.
35. Rémy C, Fouilhé N, Barba I, Sam-Laï E, Lahrech H, Cucurella MG, Izquierdo M, Moreno A, Ziegler A, Massarelli R, Décorps M, Arús C.Evidence that mobile lipids detected in rat brain glioma by H1 nuclear magnetic resonance correspond to lipid droplets.Cancer Res. 1997;57:407-414.
36. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets.Magn. Reson. Med. 1993;29:546-550.
37. 1H MR spectroscopy.NMR Biomed. 1994;7:172-180.
38. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue.NMR Biomed. 1994;7:149-155.
39. 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development.NMR Biomed. 2003;16:199-212.
40. Lahrech H, Zoula S, Farion R, Rémy C, Décorps M.In vivo measurement of the size of lipid droplets in an intracerebral glioma in the rat.Magn. Reson. Med. 2001;45:409-414.
41. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells.Biochim. Biophys. Acta, 2001;1530:47-66.
42. 13C-labelling studies indicate compartmentalized synthesis of triacylglycerols in C6 rat glioma cells.Biochim. Biophys. Acta, 2010;1801:693-701.
43. Quintero M, Cabanas ME, Arus C.A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growth.Biochim. Biophys. Acta, 2007;1771:31-44.
44. Perez Y, Lahrech H, Cabanas ME, Barnadas R, Sabes M, Remy C, Arus C.Measurement by nuclear magnetic resonance diffusion of the dimensions of the mobile lipid compartment in C6 cells.Cancer Res. 2002;62:5672-5677.
45. Barba I, Cabañas ME, Arús C.The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells.Cancer Res. 1999;59:1861-1868.
46. Milkevitch M, Jeitner TM, Beardsley N, Delikatny EJ.Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells.Biochim. Biophys. Acta, 2007;1771:1166-1176.
47. Milkevitch M, Shim H, Pilatus U, Pickup S, Wehrle JP, Samid D, Poptani H, Glickson JD, Delikatny EJ.Increases in NMR visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.Biochim. Biophys. Acta, 2005;1734:1-12.
48. Delikatny EJ, Cooper WA, Brammah S, Sathasivam N, Rideout DC.Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria.Cancer Res. 2002;62:1394-1400.
49. Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM.Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells.Br. J. Cancer, 2002;86:963-970.
50. 1H magnetic resonance spectroscopy and imaging.NMR Biomed. 2010;23:624-632.
51. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis.Nat. Med. 1999;5:1323-1327.
52. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response.Cancer Res. 1998;58:3791-3799.
53. 1H MRS in vivo pattern.Proc. Int. Soc. Magn. Reson. Med. 1996;4:976.
54. Freitas I, Pontiggia P, Barni S, Bertone V, Parente M, Novarina A, Roveta G, Gerzeli G, Stoward P.Histochemical probes for the detection of hypoxic tumour cells.Anticancer Res. 1990;10:613-622.
55. Martin S, Parton RG.Lipid droplets: a unified view of a dynamic organelle.Nat. Rev. Mol. Cell Biol. 2006;7:373-378.
56. Olofsson SO, Bostrom P, Andersson L, Rutberg M, Perman J, Boren J.Lipid droplets as dynamic organelles connecting storage and efflux of lipids.Biochim. Biophys. Acta, 2009;1791:448-458.
57. Murphy DJ.The biogenesis and functions of lipid bodies in animals, plants and microorganisms.Prog. Lipid Res. 2001;40:325-438.
58. Ohsaki Y, Cheng J, Suzuki M, Shinohara Y, Fujita A, Fujimoto T.Biogenesis of cytoplasmic lipid droplets: from the lipid ester globule in the membrane to the visible structure.Biochim. Biophys. Acta, 2009;1791:399-407.
59. Bickel PE, Tansey JT, Welte MA.PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores.Biochim. Biophys. Acta, 2009;1791:419-440.
60. Robenek H, Buers I, Hofnagel O, Robenek MJ, Troyer D, Severs NJ.Compartmentalization of proteins in lipid droplet biogenesis.Biochim. Biophys. Acta, 2009;1791:408-418.
61. Cotran RS, Kumar V, Robbins SL.Pathologic Basis of Disease, 4th edn.WB Saunders: Philadelphia, PA;1989.
62. Welte MA.Proteins under new management: lipid droplets deliver.Trends Cell Biol. 2007;17:363-369.
63. Gubern A, Barcelo-Torns M, Casas J, Barneda D, Masgrau R, Picatoste F, Balsinde J, Balboa MA, Claro E.Lipid droplet biogenesis induced by stress involves triacylglycerol synthesis that depends on group VIA phospholipase A2.J. Biol. Chem. 2009;284:5697-5708.
64. Cretu A, Brooks PC.Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities.J. Cell. Physiol. 2007;213:391-402.
65. Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ.Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.Br. J. Cancer, 2007;97:646-653.
66. Zhang X, Lin Y, Gillies RJ.Tumor pH and its measurement.J. Nucl. Med. 2010;51:1167-1170.
67. Voet D, Voet JG.Biochemistry, 3rd edn.Wiley: New York;2004.
68. Barba I, Mann P, Cabañas ME, Arús C, Gasparovic C.Mobile lipid production after confluence and pH stress in perfused C6 cells.NMR Biomed. 2001;14:33-40.
69. 1H-MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation.Magn. Reson. Med. 1999;42:248-257.
70. Rosi A, Grande S, Luciani AM, Barone P, Mlynarik V, Viti V, Guidoni L.(1H) MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids.NMR Biomed. 2004;17:76-91.
71. Blankenberg FG, Storrs RW, Naumovski L, Goralski T, Spielman D.Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy.Blood, 1996;87:1951-1956.
72. Holmes KT, Williams PG, Bloom M, Dyne M, Mountford CE, King N, Karaman M, Ninham B, Blanden R.Magnetic resonance study of lymphocytes stimulated with concanavalin A.Magn. Reson. Med. Biol. 1988;1:75-79.
73. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets.Magn. Reson. Med. 1993;29:546-550.
74. Delikatny EJ, van Holst Pellekaan CJ, King NJC.Autologous lymphocyte-monocyte co-culture increases NMR-visible and cytoplasmic lipids in the absence of increased markers of lymphocyte activation.Biochim. Biophys. Acta, 2001;1533:243-254.
75. 1H NMR investigations of tumor spheroids grown from a human glioma biopsy or from a human malignant glioma cell line.J Magn Reson B. 1995;109:39-43.
76. Rutter A, Mackinnon W, Huschtscha L, Mountford CE.A proton magnetic resonance spectroscopy study of ageing and transformed human lung fibroblasts.Exp. Gerontol. 1996;31:669-686.
77. 1H NMR visible lipids are induced by phosphonium salts and 5-fluorouracil in human breast cancer cells.Magn. Reson. Med. 2001;45:1001-1010.
78. Sathasivam N, Delikatny EJ.Time-dependent inhibition of 5-fluorouracil-induced NMR-visible lipid accumulation.Proc. Int. Soc. Magn. Reson. Med. 2002;10:2142.
79. 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells.Biochem. Pharmacol. 2003;65:1271-1280.
80. 1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles.Mol. Pharm. 2009;6:1876-1882.
81. 1H NMR spectroscopy.Cell Death Differ. 2001;8:219-224.
82. 1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo.Magn. Reson. Med. 2005;54:43-50.
83. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, Naumovski L, Tait JF.Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy.Blood, 1997;89:3778-3786.
84. 1H-NMR of apoptosis and necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis used.Radiat. Res. 2008;169:170-180.
85. 1H NMR-visible mobile lipids and lipid bodies in HuT 78 apoptotic cells.Biochim. Biophys. Acta, 2003;1634:1-14.
86. Milkevitch M, Beardsley NJ, Delikatny EJ.Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.NMR Biomed. 2010;23:473-479.
87. Leung D-J, Mawn TM, Delikatny EJ.Comparison of MRS with fluorescence for molecular imaging and determination of phospholipase isoforms.Proc. Int. Soc. Magn. Reson. Med. 2009;17:200.
88. Roman SK, Jeitner TM, Hancock R, Cooper WA, Rideout DC, Delikatny EJ.Induction of magnetic resonance-visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride.Int. J. Cancer, 1997;73:570-579.
89. Harper NJ, Sathasivam N, Delikatny EJ.The mitochondrial permeability transition inhibitor, cyclosporin A, induces NMR-visible lipid via a chlorpromazine dependent pathway.Proc. Int. Soc. Magn. Reson. Med. 2000;8:574.
90. 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts.Biochim. Biophys. Acta, 1999;1438:329-348.
91. 1H MRS-visible mobile lipids in H-ras transformed tumorigenic fibroblasts with respect to their untransformed parental cells.Cell Mol. Biol. (Noisy-le-grand), 1997;43:691-701.
92. Chen JH, Enloe BM, Weybright P, Campbell N, Dorfman D, Fletcher CD, Cory DG, Singer S.Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR spectroscopy.Magn. Reson. Med. 2002;48:602-610.
93. 1H NMR-visible lipid signal in cells.Eur. J. Biochem. 2003;270:2091-2100.
94. 1H-NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycling.Biochim. Biophys. Acta, 1996;1303:215-221.
95. 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidyl-choline specific phospholipase C.Biochem. Biophys. Res. Commun. 1997;239:868-874.
96. May GL, Wright LC, Groot Obbink K, Byleveld P, Garg M, Ahmad Z, Sorrell TC.Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide.J. Lipid Res. 1997;38:1562-1570.
97. 1H MRS.Magn. Reson. Med. 1991;19:191-198.
98. 1H-NMR-visible metabolites during radiation-induced apoptosis in MG-63 human osteosarcoma spheroids.Radiat. Res. 2006;166:734-745.
99. 1H-NMR mobile lipids are not always associated with overt apoptosis: evidence from MG-63 human osteosarcoma three-dimensional spheroids exposed to a low dose (2 Gy) of ionizing radiation.Radiat. Res. 2006;165:131-141.
100. 1H NMR studies.FEBS Lett. 1991;285:11-16.
101. Ferretti A, Knijn A, Raggi C, Sargiacomo M.High-resolution proton NMR measures mobile lipids associated with Triton-resistant membrane domains in haematopoietic K562 cells lacking or expressing caveolin-1.Eur. J. Biophys. 2002;32:83-95.
102. Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugène M, Calvo F.Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukaemia cell line.Cancer Res. 1996;56:3461-3467.
103. 1H-NMR mobile lipid intensity and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo).Biochim. Biophys. Acta, 2001;1531:111-131.
104. Le Moyec L, Tatoud R, Eugène M, Gauvillé C, Primot I, Charlemagne D, Calvo F.Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines.Br. J. Cancer, 1992;66:623-628.
105. 1H MR spectroscopic imaging of phospholipase-mediated membrane lipid release in apoptotic rat glioma in vivo.Magn. Reson. Med. 2008;59:1232-1238.
106. Haase A, Frahm J, Matthaei D, Hanicke W, Bomsdorf H, Kunz D, Tischler R.MR imaging using stimulated echoes (STEAM).Radiology, 1986;160:787-790.
107. Bottomley PA.Spatial localization in NMR spectroscopy in vivo.Ann. N.Y. Acad. Sci. 1987;508:333-348.
108. Ordidge RJ, Bendall MR, Gordon RE, Connelly A.Volume selection for in vivo biological spectroscopy. In: G, Govil CL, Khetrapal A Saran (eds).Magnetic Resonance in Biology and Medicine.McGraw-Hill: New Delhi;1985; pp.387-397.
109. 1H NMR spectroscopy.Magn. Reson. Med. 1994;32:277-284.
110. Remy C, Arus C, Ziegler A, Lai ES, Moreno A, Le Fur Y, Decorps M.In vivo, ex vivo, and in vitro one- and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances.J. Neurochem. 1994;62:166-179.
111. He Q, Shungu DC, van Zijl PC, Bhujwalla ZM, Glickson JD.Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors.J. Magn. Reson. Ser. B, 1995;106:203-211.
112. Lee SC, Huang MQ, Nelson DS, Pickup S, Wehrli S, Adegbola O, Poptani H, Delikatny EJ, Glickson JD.In vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft.NMR Biomed. 2008;21:723-733.
113. Mellon EA, Lee SC, Pickup S, Kim S, Goldstein SC, Floyd TF, Poptani H, Delikatny EJ, Reddy R, Glickson JD.Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: application to tumors and muscle ischemia.Magn. Reson. Med. 2009;62:1404-1413.
114. Sotak CH.Multiple quantum NMR spectroscopy methods for measuring the apparent self-diffusion coefficient of in vivo lactic acid.NMR Biomed. 1991;4:70-72.
115. Nicolay K, Braun KP, Graaf RA, Dijkhuizen RM, Kruiskamp MJ.Diffusion NMR spectroscopy.NMR Biomed. 2001;14:94-111.
116. Liu Y.Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.Prostate Cancer Prostatic Dis. 2006;9:230-234.
117. Wang F, Kumagai-Braesch M, Herrington MK, Larsson J, Permert J.Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system.Metabolism, 2009;58:1131-1136.
118. Ross BD, Chenevert TL, Kim B, Ben-Yoseph O.Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology.Q. Magn. Reson. Biol. Med. 1994;1:89-106.
119. Liimatainen T, Hakumaki J, Tkac I, Grohn O.Ultra-short echo time spectroscopic imaging in rats: implications for monitoring lipids in glioma gene therapy.NMR Biomed. 2006;19:554-559.
120. 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death.Cancer Res. 2003;63:3195-3201.
121. Liimatainen T, Hakumaki JM, Kauppinen RA, Ala-Korpela M.Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids.NMR Biomed. 2009;22:272-279.
122. Liimatainen T, Lehtimaki K, Ala-Korpela M, Hakumaki J.Identification of mobile cholesterol compounds in experimental gliomas by (1)H MRS in vivo: effects of ganciclovir-induced apoptosis on lipids.FEBS Lett. 2006;580:4746-4750.
123. 1H MRS.Magn. Reson. Med. 1990;13:324-331.
124. Mackinnon WB, Russell P, May GL, Mountford CE.Characterisation of human ovarian epithelial tumours (ex vivo) by proton magnetic resonance spectroscopy.Int. J. Gynaecol. Oncol. 1995;5:211-221.
125. 1H magnetic resonance spectra.Cancer Res. 1997;57:3398-3401.
126. Swindle P, McCredie S, Russell P, Himmelreich U, Khadra M, Lean C, Mountford C.Pathologic characterization of human prostate tissue with proton MR spectroscopy.Radiology, 2003;228:144-151.
127. 1H magnetic resonance spectroscopy.Int. J. Cancer, 1994;59:248-261.
128. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE.Proton magnetic resonance and human thyroid neoplasia I: discrimination between benign and malignant neoplasms.Am. J. Med. 1994;96:383-388.
129. 1H MRS: correlation with histopathology.Magn. Reson. Med. 1993;30:525-533.
130. 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance.NMR Biomed. 1993;6:111-118.
131. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE.Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology, 1997;204:661-666.
132. Ende D, Rutter A, Russell P, Mountford CE.Chemical shift imaging of human colorectal tissue (ex vivo).NMR Biomed. 1996;9:179-183.
133. 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats.NMR Biomed. 1995;8:33-40.
134. Kuesel AC, Briere KM, Halliday WC, Sutherland GR, Donnelly SM, Smith IC.Mobile lipid accumulation in necrotic tissue of high grade astrocytomas.Anticancer Res. 1996;16:1485-1489.
135. deSouza NM, Soutter WP, Rustin G, Mahon MM, Jones B, Dina R, McIndoe GA.Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome.Br. J. Cancer, 2004;90:2326-2331.
136. Mahon MM, Cox IJ, Dina R, Soutter WP, McIndoe GA, Williams AD, deSouza NM.(1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.J. Magn. Reson. Imaging, 2004;19:356-364.
137. Mahon MM, deSouza NM, Dina R, Soutter WP, McIndoe GA, Williams AD, Cox IJ.Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study.NMR Biomed. 2004;17:144-153.
138. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.NMR Biomed. 2004;17:1-9.
139. 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas.BMC Cancer, 2007;7:11.
140. Zietkowski D, Davidson RL, Eykyn TR, De Silva SS, Desouza NM, Payne GS.Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopy.NMR Biomed. 2010:382-390.
141. Stenman K, Hauksson JB, Grobner G, Stattin P, Bergh A, Riklund K.Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy.MAGMA, 2009;22:327-331.
142. 1H MRS and histological analysis.NMR Biomed. 2008;21:677-685.
143. Opstad KS, Wright AJ, Bell BA, Griffiths JR, Howe FA.Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas.J. Magn. Reson. Imaging, 2010;31:289-297.
144. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK.Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.Am. J. Neuroradiol. 1995;16:1593-1603.
145. Poptani H, Gupta RK, Jain VK, Roy R, Pandey R.Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis.Magn. Reson. Imaging, 1995;13:1019-1029.
146. Opstad KS, Ladroue C, Bell BA, Griffiths JR, Howe FA.Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification.NMR Biomed. 2007;20:763-770.
147. Wright AJ, Fellows G, Byrnes TJ, Opstad KS, McIntyre DJ, Griffiths JR, Bell BA, Clark CA, Barrick TR, Howe FA.Pattern recognition of MRSI data shows regions of glioma growth that agree with DTI markers of brain tumor infiltration.Magn. Reson. Med. 2009;62:1646-1651.
148. Calvar JA, Meli FJ, Romero C, Calcagno ML, Yanez P, Martinez AR, Lambre H, Taratuto AL, Sevlever G.Characterization of brain tumors by MRS, DWI and Ki-67 labeling index.J. Neurooncol. 2005;72:273-280.
149. Majos C, Alonso J, Aguilera C, Serrallonga M, Perez-Martin J, Acebes JJ, Arus C, Gili J.Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization.Eur. Radiol. 2003;13:582-591.
150. Negendank WG.MR spectroscopy of musculoskeletal soft-tissue tumors. [Review].Magn. Reson. Imag. Clin. N. Am. 1995;3:713-725.
151. 1H spectroscopy.J. Magn. Reson. Imaging, 2004;20:187-192.
152. Chawla S, Zhang Y, Wang S, Chaudhary S, Chou C, O'Rourke DM, Vossough A, Melhem ER, Poptani H.Proton MR spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.J. Comput. Assist Tomogr, 2010;34:836-841.
153. Sjobakk TE, Johansen R, Bathen TF, Sonnewald U, Kvistad KA, Lundgren S, Gribbestad IS.Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3 T.BMC Cancer, 2007;7:141.
154. Chernov MF, Hayashi M, Izawa M, Usukura M, Yoshida S, Ono Y, Muragaki Y, Kubo O, Hori T, Takakura K.Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.Brain Tumor Pathol. 2006;23:19-27.
155. Koeller KK, Smirniotopoulos JG, Jones RV.Primary central nervous system lymphoma: radiologic-pathologic correlation.Radiographics, 1997;17:1497-1526.
156. Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K.Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.Neurosci. Lett. 2003;342:163-166.
157. Ducreux D, Wu RH, Mikulis DJ, terBrugge K.Diffusion-weighted imaging and single-voxel MR spectroscopy in a case of malignant cerebral lymphoma.Neuroradiology, 2003;45:865-868.
158. Jayasundar R, Raghunathan P, Banerji AK.Proton MRS similarity between central nervous system non-Hodgkin lymphoma and intracranial tuberculoma.Magn. Reson. Imaging, 1995;13:489-493.
159. Burtscher IM, Skagerberg G, Geijer B, Englund E, Stahlberg F, Holtas S.Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings.Am. J. Neuroradiol. 2000;21:84-93.
160. Kizu O, Naruse S, Furuya S, Morishita H, Ide M, Maeda T, Ueda S.Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery on brain tumors.Magn. Reson. Imaging, 1998;16:197-204.
161. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T.Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.Neurosurgery, 2002;51:912-919; discussion 919-920.
162. 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.J. Neurosurg. 2004;100:835-841.
163. Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y.Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.Am. J. Neuroradiol. 2005;26:1455-1460.
164. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II.Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.Radiology, 1999;211:791-798.
165. Hein PA, Eskey CJ, Dunn JF, Hug EB.Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.Am. J. Neuroradiol. 2004;25:201-209.